Skip to content
Screener

Boston Scientific BSX Cardiovascular — Net Sales

Other segment segments

MedSurg
$1.82B+5.9%

Similar metrics at other companies

Medtronic logo
MDTCardiovascular — Net Sales
$3.8B+13.8%
Nature's Sunshine Products logo
NATRCardiovascular — Net Sales
$20.34M-0.8%
Central Garden & Pet Company logo
CENTPet — Net Sales
$476.84M+5.1%
CNH Industrial N.V. logo
CNHNet Sales — Net Sales
$2.6B+0.6%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%
Otis Worldwide logo
OTISNew Equipment — Net Sales
$1.28B+0.2%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$69.46B-56.1%
P/E18.9×-44.4×
P/S3.3×-5.3×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Boston Scientific’s 8-K, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 6:33 AM EDT
Accession
0000885725-26-000051

FAQ

What is Boston Scientific's cardiovascular — net sales?
Boston Scientific (BSX) reported cardiovascular — net sales of $3.62B in Q2 2026.
How has Boston Scientific's cardiovascular — net sales changed year-over-year?
Boston Scientific's cardiovascular — net sales increased by 8.3% year-over-year, from $3.35B to $3.62B.
What is the long-term trend for Boston Scientific's cardiovascular — net sales?
Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — net sales has grown at a 16.3% compound annual growth rate (CAGR), from $7.24B to $13.25B.
What does cardiovascular — net sales mean?
This metric measures the total revenue generated from the sale of cardiovascular medical devices after deductions for returns, allowances, and discounts. It serves as the primary indicator of market demand and commercial success for the cardiovascular product portfolio.

Ask your AI about Boston Scientific's cardiovascular — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude